Table 1.
log(CFU) | Coef. | St.Err. | t-Value | p-Value | 95% Conf | Interval | Sig. |
---|---|---|---|---|---|---|---|
S. epidermidis CIP 8155T | 0 | Reference level for microorganisms | |||||
C. albicans ATCC 10231 | −0.097 | 0.124 | −0.78 | 0.436 | −0.339 | 0.147 | |
C. albicans clinical | −0.205 | 0.124 | −1.66 | 0.098 | −0.448 | 0.038 | |
E. coli ATCC 25929 | 0.052 | 0.124 | 0.42 | 0.674 | −0.191 | 0.295 | |
E. coli ESBL clinical | 0.183 | 0.124 | 1.48 | 0.140 | −0.060 | 0.426 | |
MRSA ATCC 33592 | 0.152 | 0.124 | 1.23 | 0.221 | −0.195 | 0.395 | |
MRSA clinical strain | 0.048 | 0.124 | 0.38 | 0.700 | −0.205 | 0.291 | |
P. aeruginosa clinical | 1.306 | 0.124 | 10.55 | 0.000 | 1.063 | 1.549 | * |
S. aureus ATCC 29213 | 0.170 | 0.124 | 1.37 | 0.170 | −0.073 | 0.413 | |
Polyglecaprone 25 | 0 | Reference level for suture materials | |||||
Polyglactin 910 | 0.035 | 0.072 | 0.47 | 0.637 | −0.105 | 0.175 | |
Polydioxanone | −0.015 | 0.072 | −0.21 | 0.835 | −0.156 | 0.125 | |
No triclosan | 0 | Reference level for use of triclosan | |||||
Triclosan | −2.256 | 0.058 | −38.64 | 0.000 | −2.370 | −2.141 | * |
0 h | 0 | Reference level for hours | |||||
4 | −0.379 | 0.083 | −4.66 | 0.000 | −0.541 | −0.217 | * |
8 | −0.237 | 0.083 | −2.90 | 0.005 | −0.399 | −0.075 | ** |
24 | 0.416 | 0.083 | 5.11 | 0.000 | 0.254 | 0.578 | * |
Overall model intercept | 4.400 | 0.113 | 38.92 | 0.000 | 4.179 | 4.622 | * |
Number of obs | 1296 | Number of groups | 324 | ||||
F-test | df = 141,281 | p-value | <0.0001 | ||||
R-squared | 0.5847 | Adjusted R-squared | 0.5802 |
* p < 0.001, ** p < 0.005, Sig.: significant, df: degrees of freedom, St. Err.: standard error. Hausman test: significance of: fails to meet the asymptotic assumptions. Breusch and Pagan Lagrangian multiplier test (LM) for random effects: p-value = 0.2085.